These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28147442)

  • 41. Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease.
    Goldstein LE; Muffat JA; Cherny RA; Moir RD; Ericsson MH; Huang X; Mavros C; Coccia JA; Faget KY; Fitch KA; Masters CL; Tanzi RE; Chylack LT; Bush AI
    Lancet; 2003 Apr; 361(9365):1258-65. PubMed ID: 12699953
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biomarkers reflecting different facets of Alzheimer's disease.
    Zetterberg H
    Eur J Neurol; 2008 Nov; 15(11):1143-4. PubMed ID: 18973609
    [No Abstract]   [Full Text] [Related]  

  • 43. Potential Retinal Biomarkers in Alzheimer's Disease.
    García-Bermúdez MY; Vohra R; Freude K; Wijngaarden PV; Martin K; Thomsen MS; Aldana BI; Kolko M
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In-vivo brain neuroimaging provides a gateway for integrating biological and clinical biomarkers of Alzheimer's disease.
    Cui J; Zufferey V; Kherif F
    Curr Opin Neurol; 2015 Aug; 28(4):351-7. PubMed ID: 26132531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dementia: Alzheimer pathology and vascular factors: from mutually exclusive to interaction.
    van Norden AG; van Dijk EJ; de Laat KF; Scheltens P; Olderikkert MG; de Leeuw FE
    Biochim Biophys Acta; 2012 Mar; 1822(3):340-9. PubMed ID: 21777675
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biomarker-driven therapeutic management of Alzheimer's disease: establishing the foundations.
    Cummings J; Zhong K
    Clin Pharmacol Ther; 2014 Jan; 95(1):67-77. PubMed ID: 24105258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ocular parameters of biological ageing in HIV-infected individuals in South Africa: relationship with chronological age and systemic biomarkers of ageing.
    Pathai S; Shiels PG; Weiss HA; Gilbert CE; Peto T; Bekker LG; Wood R; Wong TY; Lawn SD
    Mech Ageing Dev; 2013 Sep; 134(9):400-6. PubMed ID: 23994067
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biomarkers of Alzheimer's disease and mild cognitive impairment: a current perspective.
    Lewczuk P; Mroczko B; Fagan A; Kornhuber J
    Adv Med Sci; 2015 Mar; 60(1):76-82. PubMed ID: 25579841
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Excessive hydrogen peroxide enhances the attachment of amyloid β1-42 in the lens epithelium of UPL rats, a hereditary model for cataracts.
    Nagai N; Ito Y
    Toxicology; 2014 Jan; 315():55-64. PubMed ID: 23941810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Will PET amyloid imaging lead to overdiagnosis of Alzheimer dementia?
    Dubroff JG; Nasrallah IM
    Acad Radiol; 2015 Aug; 22(8):988-94. PubMed ID: 26100192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alzheimer Disease.
    Morley JE; Farr SA; Nguyen AD
    Clin Geriatr Med; 2018 Nov; 34(4):591-601. PubMed ID: 30336989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Delineating Alzheimer's disease progression with MGAT3, a biomarker for improved prognosis and personalized therapy.
    Fiala M; Porter V
    Biomark Med; 2011 Oct; 5(5):645-7. PubMed ID: 22003913
    [No Abstract]   [Full Text] [Related]  

  • 54. [Alzheimer's disease and geriatric eye diseases in the aspect of amyloid genesis].
    Ermilov VV; Tiurenkov IN; Nesterova AA; Zagrebin VA
    Arkh Patol; 2013; 75(2):37-42. PubMed ID: 24006764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia.
    Ferrer I
    Prog Neurobiol; 2012 Apr; 97(1):38-51. PubMed ID: 22459297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Retinal Scan for Alzheimer Disease.
    Abbasi J
    JAMA; 2017 Oct; 318(14):1314. PubMed ID: 29049570
    [No Abstract]   [Full Text] [Related]  

  • 57. Dementia in 2014. Towards early diagnosis in Alzheimer disease.
    Nordberg A
    Nat Rev Neurol; 2015 Feb; 11(2):69-70. PubMed ID: 25623789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Great Debate in Diagnosing Alzheimer Disease: More Than Just a β Test.
    Villain N; Paretsky MS
    Neurology; 2024 Sep; 103(5):e209836. PubMed ID: 39167737
    [No Abstract]   [Full Text] [Related]  

  • 59. Retinal Biomarkers for Alzheimer Disease: The Facts and the Future.
    Yuan A; Lee CS
    Asia Pac J Ophthalmol (Phila); 2022 Mar-Apr 01; 11(2):140-148. PubMed ID: 35533333
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alzheimer disease: Could tear proteins be biomarkers for Alzheimer disease?
    Wood H
    Nat Rev Neurol; 2016 Aug; 12(8):432. PubMed ID: 27389093
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.